GSK releases Synflorix, pediatric pneumococcal vaccine, in Korea
Published: 2010-08-03 06:57:00
Updated: 2010-08-03 06:57:00
GlaxoSmithKline (GSK) said it has supplied to the domestic hospitals and clinics its Synflorix a paediatric pneumococcal vaccine to protect against life-threatening diseases such as meningitis and bacteraemic pneumonia, as well as middle ear infections.
GSK’s new vaccine indicated for active i...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
